Cargando…

Efficacy of Valganciclovir Treatment Depends on the Severity of Hearing Dysfunction in Symptomatic Infants with Congenital Cytomegalovirus Infection

Although earlier studies have shown that antiviral treatment regimens using valganciclovir (VGCV) improved hearing function in some infants with congenital cytomegalovirus (CMV) infection; its efficacy on the severity of hearing dysfunction is unclear. We conducted a prospective study among 26 infan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohyama, Shohei, Morioka, Ichiro, Fukushima, Sachiyo, Yamana, Keiji, Nishida, Kosuke, Iwatani, Sota, Fujioka, Kazumichi, Matsumoto, Hisayuki, Imanishi, Takamitsu, Nakamachi, Yuji, Deguchi, Masashi, Tanimura, Kenji, Iijima, Kazumoto, Yamada, Hideto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471816/ https://www.ncbi.nlm.nih.gov/pubmed/30893926 http://dx.doi.org/10.3390/ijms20061388

Ejemplares similares

Diagnostic Value of Cytomegalovirus IgM Antibodies at Birth in PCR-Confirmed Congenital Cytomegalovirus Infection
por: Ohyama, Shohei, et al.
Publicado: (2019)

Pulmonary Hypoplasia Caused by Fetal Ascites in Congenital Cytomegalovirus Infection Despite Fetal Therapy
por: Fujioka, Kazumichi, et al.
Publicado: (2017)

Gestational age-dependency of height and body mass index trajectories during the first 3 years in Japanese small-for-gestational age children
por: Maeyama, Kaori, et al.
Publicado: (2016)

Intraventricular Hemorrhage Due to Coagulopathy After Vitamin K Administration in a Preterm Infant With Maternal Crohn Disease
por: Fujioka, Kazumichi, et al.
Publicado: (2017)

Incidence and Neonatal Risk factors of Short Stature and Growth Hormone treatment in Japanese Preterm Infants Born Small for Gestational Age
por: Matsumoto, Masaaki, et al.
Publicado: (2019)

Fluorescent protein-based detection of unconjugated bilirubin in newborn serum
por: Iwatani, Sota, et al.
Publicado: (2016)

Correlation of cytomegalovirus viral load between whole blood and plasma of congenital cytomegalovirus infection under valganciclovir treatment
por: Torii, Yuka, et al.
Publicado: (2023)

A Novel Method for Measuring Serum Unbound Bilirubin Levels Using Glucose Oxidase–Peroxidase and Bilirubin-Inducible Fluorescent Protein (UnaG): No Influence of Direct Bilirubin
por: Iwatani, Sota, et al.
Publicado: (2020)

Changes in awareness and knowledge concerning mother-to-child infections among Japanese pregnant women between 2012 and 2018
por: Suga, Shutaro, et al.
Publicado: (2021)

Efficacy and safety of valganciclovir in patients with symptomatic congenital cytomegalovirus disease: Study Protocol Clinical Trial (SPIRIT Compliant)
por: Morioka, Ichiro, et al.
Publicado: (2020)

The Current Challenges in Developing Biological and Clinical Predictors of Congenital Cytomegalovirus Infection
por: Tanimura, Kenji, et al.
Publicado: (2021)

Involvement of WNT Signaling in the Regulation of Gestational Age-Dependent Umbilical Cord-Derived Mesenchymal Stem Cell Proliferation
por: Iwatani, Sota, et al.
Publicado: (2017)

Transcutaneous bilirubin monitoring predicts unexplained late-onset hemolysis in a very low birthweight infant
por: Nagasaka, Miwako, et al.
Publicado: (2016)

Clinical and ultrasound features associated with congenital cytomegalovirus infection as potential predictors for targeted newborn screening in high-risk pregnancies
por: Imafuku, Hitomi, et al.
Publicado: (2020)

Oral Valganciclovir Therapy in Infants Aged ≤2 Months with Congenital Cytomegalovirus Disease: A Multicenter, Single-Arm, Open-Label Clinical Trial in Japan
por: Morioka, Ichiro, et al.
Publicado: (2022)

Gestational Age-Dependent Increase of Survival Motor Neuron Protein in Umbilical Cord-Derived Mesenchymal Stem Cells
por: Iwatani, Sota, et al.
Publicado: (2017)

Comparison of Two Hepatitis B Vaccination Strategies Targeting Vertical Transmission: A 10-Year Japanese Multicenter Prospective Cohort Study
por: Nishimura, Koji, et al.
Publicado: (2021)

An unusual case of congenital cytomegalovirus infection-related retinopathy
por: Tagami, Mizuki, et al.
Publicado: (2016)

Cytomegalovirus retinitis treated with valganciclovir in Wegener’s granulomatosis
por: Kabata, Yoshiaki, et al.
Publicado: (2012)

Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients
por: Patil, A Jayaprakash, et al.
Publicado: (2010)

Neurodevelopmental Outcomes at 18 Months of Corrected Age for Late Preterm Infants Born at 34 and 35 Gestational Weeks
por: Nakasone, Ruka, et al.
Publicado: (2021)

Association of a vascular endothelial growth factor polymorphism with the development of bronchopulmonary dysplasia in Japanese premature newborns
por: Fujioka, Kazumichi, et al.
Publicado: (2014)

Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients
por: Doesch, Andreas O, et al.
Publicado: (2012)

High frequency of valganciclovir underdosing for cytomegalovirus prophylaxis after renal transplantation
por: Rissling, Olesja, et al.
Publicado: (2018)

1146. Thrombocytosis in Infants with Congenital Cytomegalovirus Infection Being Treated with Valganciclovir
por: Murtagh, Kathleen, et al.
Publicado: (2020)

Change in Viral Load during Antiviral Therapy Is Not Useful for the Prediction of Hearing Dysfunction in Symptomatic Congenital Cytomegalovirus Infection
por: Kido, Takumi, et al.
Publicado: (2021)

Successful Management of an Extremely Premature Infant with Congenital Candidiasis
por: Iwatani, Sota, et al.
Publicado: (2013)

Efficacy of Extended Valganciclovir Prophylaxis in Preventing Cytomegalovirus Infection in Pediatric Kidney Transplantation
por: Hashim, Faris, et al.
Publicado: (2014)

Assessment of mitochondrial toxicity in newborns and infants with congenital cytomegalovirus infection treated with valganciclovir
por: Ortiz-Gracia, Alba, et al.
Publicado: (2022)

Age-specific percentile-based reference curve of serum procalcitonin concentrations in Japanese preterm infants
por: Fukuzumi, Noriko, et al.
Publicado: (2016)

False positive cases of elevated tetradecenoyl carnitine in newborn mass screening showed significant loss of body weight
por: Bo, Ryosuke, et al.
Publicado: (2020)

Recombinant human thrombomodulin attenuated sepsis severity in a non-surgical preterm mouse model
por: Ashina, Mariko, et al.
Publicado: (2020)

Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis
por: Vaziri, Siavash, et al.
Publicado: (2014)

The Association Between Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in the Era of Antiviral Valganciclovir Prophylaxis
por: Klimczak-Tomaniak, Dominika, et al.
Publicado: (2019)

Potential Biomarkers for Predicting Congenital Cytomegalovirus Infection
por: Tanimura, Kenji, et al.
Publicado: (2018)

Valganciclovir for Cytomegalovirus Prevention in Solid Organ Transplant Patients: An Evidence-Based Reassessment of Safety and Efficacy
por: Kalil, Andre C., et al.
Publicado: (2009)

Long-term results of oral valganciclovir for treatment of anterior segment inflammation secondary to cytomegalovirus infection
por: Wong, Victoria WY, et al.
Publicado: (2012)

An infant with refractory cytomegalovirus‐induced thrombocytopenia
por: Uemura, Suguru, et al.
Publicado: (2019)

Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients
por: Kim, Jong Man, et al.
Publicado: (2015)

Case report: severe cytomegalovirus primary infection in an immunocompetent adult with disseminated intravascular coagulation treated with valganciclovir
por: Müller, Niklas F., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p0g8hhon8kq9tk9s9iq0m7qnuo